Arteris, Inc. (NASDAQ:AIP - Get Free Report) VP Paul L. Alpern sold 10,000 shares of the business's stock in a transaction dated Monday, September 15th. The shares were sold at an average price of $8.88, for a total transaction of $88,800.00. Following the completion of the sale, the vice president owned 73,587 shares of the company's stock, valued at approximately $653,452.56. This represents a 11.96% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link.
Arteris Price Performance
Shares of NASDAQ:AIP traded down $0.42 during trading hours on Friday, hitting $9.87. The company's stock had a trading volume of 726,449 shares, compared to its average volume of 494,242. The firm's fifty day moving average price is $9.49 and its 200 day moving average price is $8.24. Arteris, Inc. has a 52 week low of $5.46 and a 52 week high of $14.29. The company has a market capitalization of $420.96 million, a price-to-earnings ratio of -12.04 and a beta of 1.44.
Arteris (NASDAQ:AIP - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported ($0.11) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.11). Arteris had a negative net margin of 52.41% and a negative return on equity of 8,546.17%. The firm had revenue of $16.50 million for the quarter, compared to the consensus estimate of $16.35 million. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, equities research analysts predict that Arteris, Inc. will post -0.73 earnings per share for the current fiscal year.
Analyst Ratings Changes
A number of brokerages have recently issued reports on AIP. Wall Street Zen raised shares of Arteris from a "sell" rating to a "hold" rating in a research report on Monday, September 15th. TD Cowen boosted their target price on shares of Arteris from $12.00 to $15.00 and gave the stock a "buy" rating in a research report on Wednesday, August 6th. Three research analysts have rated the stock with a Buy rating, According to MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus price target of $15.00.
Check Out Our Latest Stock Analysis on AIP
Institutional Trading of Arteris
Several institutional investors and hedge funds have recently bought and sold shares of the business. Acadian Asset Management LLC boosted its stake in Arteris by 40.6% during the 1st quarter. Acadian Asset Management LLC now owns 900,723 shares of the company's stock worth $6,222,000 after purchasing an additional 260,277 shares during the period. AQR Capital Management LLC acquired a new stake in Arteris during the 1st quarter worth $1,621,000. Federated Hermes Inc. boosted its stake in Arteris by 97.2% during the 1st quarter. Federated Hermes Inc. now owns 327,119 shares of the company's stock worth $2,260,000 after purchasing an additional 161,241 shares during the period. Franklin Resources Inc. boosted its stake in Arteris by 9.6% during the 2nd quarter. Franklin Resources Inc. now owns 1,637,171 shares of the company's stock worth $15,602,000 after purchasing an additional 142,936 shares during the period. Finally, Next Century Growth Investors LLC boosted its stake in Arteris by 46.4% during the 1st quarter. Next Century Growth Investors LLC now owns 407,721 shares of the company's stock worth $2,817,000 after purchasing an additional 129,143 shares during the period. Hedge funds and other institutional investors own 64.36% of the company's stock.
Arteris Company Profile
(
Get Free Report)
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Read More

Before you consider Arteris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.
While Arteris currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.